Basic Information
| LncRNA/CircRNA Name | DLX6-AS1 |
| Synonyms | NA |
| Region | GRCh38_7:96955141-97014065 |
| Ensemble | ENSG00000231764 |
| Refseq | NR_015448 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | laryngeal cancer |
| ICD-0-3 | C32 |
| Methods | qPCR, Western blot etc. |
| Sample | laryngeal cancer tissues compared with adjacent normal tissues,cell lines (HEp-2 and Tu-177) |
| Expression Pattern | up-regulated |
| Function Description | lncRNA DLX6-AS1 had increased expression in tumor tissues compared with adjacent normal tissues and in higher clinical stages compared with lower stages, which was associated with poor prognosis.DLX6-AS1 Expression Is Correlated with the Prognosis of Laryngeal Cancer Patients |
| Pubmed ID | 32368147 |
| Year | 2020 |
| Title | lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway. |
External Links
| Links for DLX6-AS1 | GenBank HGNC NONCODE |
| Links for laryngeal cancer | OMIM COSMIC |